Shafique Virani is currently CEO in Residence at BridgeBio, LLC and CEO of Navire Pharma based in Palo Alto, CA. Until June 2017, he was Vice President, Global Head of Neuroscience, Ophthalmology & Rare disease (NORD) Roche Partnering. Shafique’s responsibilities in this role encompassed all partnering activities within Roche’s NORD franchise, from academic collaborations to licensing and acquisitions. Shafique joined Roche in 2004 and served various roles within medical affairs, marketing and business development in the UK, USA and Switzerland until 2012, when he transitioned to South San Francisco. Shafique is trained as a neurosurgeon in Cambridge, UK and Boston, USA and holds the Fellowship of the Royal College of Surgeons of England.